Piracovi 200 (Molnupiravir)

Piracovi 200 (Molnupiravir): Overview

Piracovi 200 contains molnupiravir, an antiviral medicine supplied as 200 mg tablets. It is used under medical supervision for certain adults with mild to moderate COVID-19 who have a higher risk of progressing to severe illness. Treatment should begin only when prescribed by a qualified healthcare professional.

Molnupiravir works against SARS-CoV-2, the virus that causes COVID-19. It is not a substitute for vaccination, does not treat every respiratory infection, and is not intended for routine prevention of COVID-19.

Uses of Piracovi 200 (Molnupiravir)

After entering infected cells, molnupiravir is converted into an active form that interferes with the virus’s ability to copy its genetic material. This can reduce the virus’s capacity to multiply when the medicine is used at the appropriate stage of illness.

• Treatment of selected adults with mild to moderate COVID-19.
• Use in adults considered at increased risk of progressing to severe COVID-19, when a healthcare professional determines that molnupiravir is appropriate.
• An alternative antiviral option when preferred authorised treatments are not accessible, suitable, or clinically appropriate, according to local medical guidance.
• Management of an active COVID-19 infection; it should not be used as a general preventive medicine.

How to Take Piracovi 200 (Molnupiravir)

Take Piracovi 200 exactly as directed by your doctor or pharmacist. Swallow the tablets with water, and do not crush, chew, or open them unless a healthcare professional specifically instructs you to do so. Treatment is intended for a limited course and should be started promptly within the period recommended by the prescriber after COVID-19 symptoms begin or testing confirms infection.

Do not change the amount, frequency, or duration on your own. If you miss a dose, contact your prescriber or pharmacist for instructions rather than doubling the next dose. Tell your healthcare professional about all medicines, supplements, allergies, and existing health conditions before treatment.

Strengths available

• Piracovi 200 mg – 40-tablet pack
• Piracovi 200 mg – 80-tablet pack
• Piracovi 200 mg – 120-tablet pack

Each tablet contains 200 mg of molnupiravir. The pack size changes the number of tablets supplied, not the amount of active ingredient in an individual tablet. A larger pack is not automatically more suitable or more effective; your prescribed treatment and supply should be determined by a healthcare professional.

Possible Side Effects

• Diarrhea, nausea, or vomiting.
• Dizziness or headache.
• Skin rash, itching, or other mild allergic-type reactions.
• Changes in blood tests, including liver-related results, which may be detected during medical monitoring.
• Seek urgent medical help for swelling of the face or throat, breathing difficulty, widespread blistering rash, or other signs of a serious allergic reaction.

Precautions & Warnings

• Do not use molnupiravir during pregnancy unless a specialist has specifically assessed the situation and advised otherwise. It may harm an unborn baby.
• People who could become pregnant should discuss reliable contraception with a healthcare professional during treatment and for the period advised after the final dose.
• Men with partners who could become pregnant should follow the contraception precautions provided by their prescriber.
• Molnupiravir is not authorised for children or adolescents who are still growing, and it is not generally used in patients under 18.
• Tell your doctor if you are breastfeeding, have liver or kidney problems, or have received another COVID-19 antiviral.
• Do not use leftover tablets or share this medicine with another person. COVID-19 symptoms that worsen, including shortness of breath or persistent chest pain, require prompt medical attention.

Storage

Keep Piracovi 200 in its original packaging, away from excess heat, moisture, and direct light. Store it out of the reach of children. Check the expiry date before use, and ask a pharmacist how to dispose of unused tablets.

Frequently Asked Questions about Piracovi 200 (Molnupiravir)

Is Piracovi 200 suitable for every person with COVID-19?

No. Piracovi 200 is intended for selected adults with mild to moderate COVID-19 who have risk factors for severe disease. A clinician must decide whether it is appropriate, taking account of symptom timing, medical history, pregnancy status, other medicines, and available treatment alternatives. It should not be used for uncomplicated infections without professional assessment.

What does the 200 mg strength mean?

The 200 mg designation refers to the amount of molnupiravir in one Piracovi tablet. It does not indicate that the medicine is stronger or more suitable for everyone than another antiviral. The available 40-, 80-, and 120-tablet packs contain the same tablet strength; only the number of tablets differs.

Can I take Piracovi 200 to prevent COVID-19 after exposure?

Piracovi 200 is not a routine post-exposure or pre-exposure preventive medicine. It is used for certain people with an active COVID-19 infection, following a healthcare professional’s assessment. If you have been exposed, contact a clinician or follow current public-health testing and monitoring guidance rather than taking tablets without a prescription.

Why must pregnancy be discussed before using molnupiravir?

Molnupiravir may affect an unborn baby, so it is generally avoided during pregnancy. Anyone who is pregnant, planning pregnancy, or able to become pregnant should speak with a healthcare professional before treatment. Contraception advice may also apply during treatment and afterward, and breastfeeding plans should be reviewed with the prescriber.

What should I do if my COVID-19 symptoms become worse?

Contact a healthcare professional promptly if symptoms are not improving or become more severe. Seek urgent medical care for trouble breathing, persistent chest pain or pressure, new confusion, inability to stay awake, or bluish or grey skin, lips, or nail beds. Do not respond to worsening illness by taking extra Piracovi 200 tablets.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting any medication.